As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...
The project, approved in 2008, was meant to anchor the industry’s next phase of growth. Nearly two decades later, the site remains largely idle. On a quiet December 11 afternoon, entering the API ...
Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.
The Active Pharmaceutical Ingredient (API) is the most important part of any drug. The API, as the name would suggest, is the chemical part of any capsule or tablet that works on the disease condition ...
In this interview, News Medical speaks with Guillaume Bentzinger, Project Manager at Novalix; Luis Carrillo, Managing Director at De Dietrich France; Philippe Robin CEO of Alysophil; and Alejandro ...
The Global Active Pharmaceutical Ingredients (API) Market is valued at USD 209.80 Billion in 2024 and is projected to reach a value of USD 445.7 Billion by 2035 at a CAGR (Compound Annual Growth Rate) ...
In spring 2020, Ryotaro Katsura, president of Katsura Chemical in Japan, was fretting over a delayed shipment of a pharmaceutical raw material from India. “No worries, no worries,” the Indian supplier ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する